Mucosa-associated invariant T (MAIT) cells contribute to host immune protection againstM ucosa-associated invariant T (MAIT) cells are relatively abundant in humans, comprising 1 to 10% of peripheral blood T cells (1-3) and up to 45% of liver lymphocytes (4, 5). Lower frequencies are present in the gastrointestinal (GI) tract, lung, and mesenteric lymph nodes (MLNs) (2, 6). Classically defined by the expression of a semi-invariant TRAV1-2/TRAJ33 (V␣7.2/J␣33) T cell receptor alpha (TCR␣) chain (7), MAIT cells recognize microbial vitamin B 2 metabolites presented in association with the major histocompatibility complex class I-related molecule MR1 (8-12). These conserved features bestow widespread reactivity against an array of bacterial and fungal species (13, 14), allowing MAIT cells to act as innate-like antimicrobial guardians at mucosal sites via the secretion of proinflammatory and tissue-protective cytokines, such as interleukin 17 (IL-17), tumor necrosis factor (TNF), and gamma interferon (IFN-␥) (2, 9).The abundance of MAIT cells in peripheral blood and mucosal tissues, combined with their broad reactivity and functional properties, suggests a key role in primary immune defense and various pathological states (2, 9). Indeed, multiple reports have described a loss of circulating MAIT cells in diseases with an inflammatory component, such as obesity and type II diabetes (15), inflammatory bowel disease (16), tuberculosis (2, 17), and human immunodeficiency virus (HIV) disease (18)(19)(20). MAIT cells also appear to be highly activated under these conditions and may be recruited to tissue sites of inflammation (15,16,19).Although MAIT cells are neither directly activated nor directly infected by HIV (20), previous studies have consistently demonstrated selective depletion of this subset in the peripheral blood of HIV-infected individuals and simian immunodeficiency virus (SIV)-infected Asian macaques (18)(19)(20). However, the underlying mechanisms remain unclear. It is established that CD4 ϩ T cells are lost in the GI tract during HIV/SIV infection (21,22). Moreover, epithelial integrity is compromised by the associated immunopathology, leading to microbial translocation and systemic immune activation (23,24). This process could feasibly drive MAIT cell